Sei Investments Co. Raises Position in HealthEquity, Inc. (NASDAQ:HQY)

Sei Investments Co. boosted its position in HealthEquity, Inc. (NASDAQ:HQY) by 13.2% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 645,244 shares of the company’s stock after purchasing an additional 75,193 shares during the period. Sei Investments Co. owned about 0.74% of HealthEquity worth $55,620,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. Cape Investment Advisory Inc. purchased a new stake in HealthEquity in the 4th quarter worth approximately $27,000. Rise Advisors LLC bought a new stake in HealthEquity during the first quarter valued at $28,000. International Assets Investment Management LLC purchased a new position in HealthEquity during the second quarter worth about $35,000. YHB Investment Advisors Inc. bought a new position in HealthEquity in the 1st quarter worth about $40,000. Finally, Fidelis Capital Partners LLC purchased a new stake in HealthEquity in the first quarter valued at approximately $42,000. 99.55% of the stock is owned by institutional investors.

HealthEquity Trading Up 1.2 %

NASDAQ HQY opened at $79.53 on Monday. The stock has a market cap of $6.92 billion, a P/E ratio of 86.45, a price-to-earnings-growth ratio of 1.19 and a beta of 0.52. HealthEquity, Inc. has a fifty-two week low of $61.81 and a fifty-two week high of $88.26. The stock has a 50 day simple moving average of $76.17 and a two-hundred day simple moving average of $79.31. The company has a debt-to-equity ratio of 0.51, a quick ratio of 4.10 and a current ratio of 4.10.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on HQY shares. Barrington Research reiterated an “outperform” rating and set a $105.00 price objective on shares of HealthEquity in a research report on Friday. Raymond James boosted their price objective on shares of HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a report on Friday, June 7th. Wells Fargo & Company increased their target price on shares of HealthEquity from $107.00 to $110.00 and gave the company an “overweight” rating in a report on Thursday, June 20th. KeyCorp boosted their price target on shares of HealthEquity from $95.00 to $100.00 and gave the stock an “overweight” rating in a research note on Wednesday, June 5th. Finally, Deutsche Bank Aktiengesellschaft raised their price objective on HealthEquity from $102.00 to $103.00 and gave the company a “buy” rating in a research note on Wednesday, September 4th. One research analyst has rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $103.83.

Insider Buying and Selling

In other HealthEquity news, Director Frank Corvino sold 7,705 shares of the business’s stock in a transaction on Monday, July 8th. The shares were sold at an average price of $81.89, for a total transaction of $630,962.45. Following the transaction, the director now directly owns 6,070 shares of the company’s stock, valued at approximately $497,072.30. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other news, Vice Chairman Stephen Neeleman sold 35,000 shares of the firm’s stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $79.86, for a total value of $2,795,100.00. Following the completion of the transaction, the insider now owns 89,769 shares in the company, valued at approximately $7,168,952.34. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Frank Corvino sold 7,705 shares of HealthEquity stock in a transaction that occurred on Monday, July 8th. The shares were sold at an average price of $81.89, for a total value of $630,962.45. Following the sale, the director now owns 6,070 shares in the company, valued at $497,072.30. The disclosure for this sale can be found here. 2.20% of the stock is currently owned by insiders.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.